Next Issue

May 2025

Don’t miss out – sign up to our free industry-leading magazine and newsletters

Big pharma's efforts to market drugs and vaccines in China and its related challenges have come up in recent quarterly earnings calls, and next month's issue will delve into possible ramifications this could have for the future. Also, the May issue will include the latest on European data regulations, obesity drug compounders and more. 

EDITORIAL

Editor |Manasi Vaidya

Deputy Editor | Ross Law

Writers | Abigail Beaney, Akosua Mireku, Frankie Fattorini, Irena Maragkou, Jenna Philpott

Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo

ADVERTISING

Sales Manager | Tom McCormick
+44 207 8669440

Pharma Technology Focus is powered by H5mag
Read past issues of Pharma Technology Focushere

Go to article: Home | Are European biopharma manufacturers ‘nearshoring’?Go to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: MilliporeSigmaGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: Frewitt Company InsightGo to article: In DepthGo to article: Are European biopharma manufacturers ‘nearshoring’?Go to article: Inborn errors of metabolism elicit unique challenges for therapy developmentGo to article: GLP-1RAs and opioid use disorder: a new frontier in addiction treatmentGo to article: European agencies catch up with speedier regulatory pathways for CGTs in the USGo to article: USAID funding fallout: sponsors, and agencies may have to fill funding gapGo to article: Pfizer’s bet on gene therapies in haemophilia has been a bustGo to article: SimtraGo to article: Zenatek Company InsightGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Buyer's GuidesGo to article: Next issue